Article

Forbes on 2023-12-14 17:35

Moderna Stock Soars After Cancer Vaccine’s Strong Test Results

he drug company’s latest vaccine, built from the same mRNA technology that created the Covid-19 vaccine, was found to significantly reduce risk of ...

Seattle

Related news

Moderna: Early coronavirus vaccine results are encouraging journalrecord.com
China , Cambridge , Seattle
Early coronavirus vaccine results encouraging, Moderna says reviewjournal.com
Phase 1 , Cambridge , International District , Seattle
Woman who took part in Seattle’s Moderna trial hopes for vaccine’s approval KING 5
Seattle
MCriteo stock soars on strong results, outlook marketwatch.com
Facebook parent Meta posts solid 1Q results, stock soars seattletimes.com
Menlo Park , Wall Street
IModerna stock price soars to record highs as Covid-19 vaccine shows 94.5% efficacy invezz.com
Stock market opens higher after strong Apple, Boeing results TimesDaily.com
BBaidu Stock Soars On Strong Second-Quarter Results barrons.com
Wall Street , China
Unisys stock soars as federal contracts drive strong results bizjournals.com
Disney Stock Soars 6% After Strong Earnings—Biggest Gain Of 2023 Forbes
Moderna Stock Crash Has Wiped Nearly $100 Billion As Flu Vaccine Results Trigger Latest Plunge Forbes
Wall Street , France , Cambridge , Plunge
U.S. stock futures soar on positive results from Moderna vaccine trial dailyherald.com
California
Moderna unveiled encouraging coronavirus vaccine results. Then top execs dumped nearly $30 million of stock CNN
Phase 1 , Wall Street , New York
Moderna stock jumps after key step toward COVID-19 vaccine results New York Post
Moderna says vaccine efficacy strong 6 months out nwaonline.com
France , Israel , Argentina , Quilmes , United States
Moderna to fund coronavirus vaccine with $1.3 billion stock sale New York Post
Wall Street
The Moderna Vaccine’s Antibodies May Not Last As Long As We Hoped Forbes
United States